<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      Lipids
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/lipids" data-history-node-id="923" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
        <p style="border:none; padding:0in">
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Lipids – Jonathan Davis
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
        </p>
       </div>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Background
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="vertical-align:baseline">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               1º Prevention: pts  at increased risk who have not yet had a vascular event
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="vertical-align:baseline">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               2º Prevention: pts  with pre-existing occlusive vascular disease or ASCVD (e.g., stroke, TIA, CAD + angina, ACS, coronary or arterial revascularization, PAD)
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="vertical-align:baseline">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Screening:
              </span>
             </span>
             <b>
             </b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               USPSTF 2016 Guidelines: adults 40-75yrs
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
         <ul>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 ACC/AHA 2018 Guideline: adults 21-75 q 4-6yrs; <21yrs  if strong fam hx
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
         </ul>
        </li>
       </ul>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Evaluation
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="vertical-align:baseline">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Fasting vs Non-Fasting Lipid Panel.
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
         <ul>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Triglycerides
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  are most impacted by non-fasting testing which can artificially lower LDL-C depending on how the laboratory measures/calculates LDL. Consider fasting lipid panels when triglyceride levels are high
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
         </ul>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="vertical-align:baseline">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Consider 2º causes of HLD in initial workup: hypothyroidism, DM, EtOH use, smoking, liver disease, nephrotic syndrome, CKD, meds (e.g., thiazide, glucocorticoids)
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             Management
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="vertical-align:baseline">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Lifestyle changes:
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
         <ul>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Heart Healthy Diet:
                 </span>
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style='font-family:"Times New Roman",serif'>
                 <span style="color:black">
                  ↓
                 </span>
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  trans/saturated fats, choose skim milk, low-fat dairy products
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Emphasizes fruits, vegetables, whole grains, poultry, fish, nuts and olive oil, while limiting
                 </span>
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 red
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  and processed meats, sodium and sugar-sweetened foods and beverages
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Promote a healthy weight, regular exercise, smoking cessation, limit EtOH
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
         </ul>
        </li>
       </ul>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <b>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Statin Therapy
              </span>
             </span>
            </span>
           </b>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:12.0pt">
          <span style="line-height:107%">
           <span style="font-family:Palatino">
            Initiate as outlined in the following algorithms (Note: check AST/ALT prior to initiation)
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p>
       </p>
       <p>
        <img alt="Lipid One" data-entity-type="file" data-entity-uuid="cf7f75ad-7e26-48a4-9605-0edc0ced7181" src="/sites/default/files/inline-images/LipidOne.png"/>
       </p>
       <p>
       </p>
       <p>
        <img alt="Lipid Two" data-entity-type="file" data-entity-uuid="f8a5c2ae-1d7e-4258-97af-0daea5129a13" src="/sites/default/files/inline-images/LipidTwo.png"/>
       </p>
       <p>
       </p>
       <div class="WordSection1">
        <table class="GridTable47" style="border-collapse:collapse; border:none" width="349">
         <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
      <th>2</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>High Intensity  ( $LDL-C by &gt; 50%)</td>
      <td>Moderate Intensity  ($LDL-C by 30% - 49%)</td>
      <td>Low Intensity  ($LDL-C by &lt;30%)</td>
    </tr>
    <tr>
      <td>Atorvastatin (40mg) 80mg* Rosuvastatin 20mg (40mg)</td>
      <td>Atorvastatin 10mg (20mg) Rosuvastatin (5mg) 10mg Simvastatin 20 - 40mg</td>
      <td>Simvastatin 10mg</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>Pravastatin 40mg (80mg) Lovastatin 40mg (80mg) Fluvastatin XL 80mg Fluvastatin 40mg BID Pitavastatin 1-4mg</td>
      <td>Pravastatin 10-20mg Lovastatin 20 mg Fluvastatin 20-40mg</td>
    </tr>
  </tbody>
</table>
        </table>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               *Bold denotes dosing with RTC proven LDL lowering benefit
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <p>
        </p>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <b>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Statin Side effects
                </span>
               </span>
              </span>
             </b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                :
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Myalgias: bilateral involving large muscle groups, onset within weeks of initiation of therapy and should resolve within weeks of cessation
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Spectrum of statin associated muscle symptoms (SAMS) include myalgias, myopathy, rhabdomyolysis, autoimmune myopathy, etc.
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="vertical-align:baseline">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Consider
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    evaluation with CK, BMP, TSH, and vitamin D
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="vertical-align:baseline">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    ACC has a “Statin Intolerance Calculator” to help assess etiology of symptoms
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
        <p>
        </p>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                Additional Information
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 If patient is not tolerating a statin, consider:
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="vertical-align:baseline">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Holding statin until symptoms resolve and trialing lower dose or alternative statin (Pravastatin and Fluvastatin may have lower risks of myopathy)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="vertical-align:baseline">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Every other day dosing with atorvastatin and rosuvastatin (longer half-lives)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  If repeated
                 </span>
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 failed attempts, consider
                 <b>
                  alternative agents
                 </b>
                 : Ezetimibe
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  10mg daily
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-left:25px">
        </p>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="vertical-align:baseline">
             <span style="font-family:Calibri,sans-serif">
              <b>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Hypertriglyceridemia
                </span>
               </span>
              </b>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                :
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Moderate: TG 175-499 mg/dL; Severe: TG > 500 mg/dL
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="vertical-align:baseline">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Focus
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   on addressing lifestyle factors and stopping medication that increase TG’s  (HCTZ, some BB’s, estrogens, some ART, antipsychotics)
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="vertical-align:baseline">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Consider
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   medical therapy when TG> 500mg/dL to $ risk of pancreatitis with:
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
            <ul>
             <li style="margin-left: 10px;">
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    Omega
                   </span>
                  </span>
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    <span style="color:black">
                     -3-fatty acids: 4gms daily or Vascepa 4gm daily
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li style="margin-left: 10px;">
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    Fibrates
                   </span>
                  </span>
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    <span style="color:black">
                     : Fenofibrate 120mg daily (avoid in CKD), Gemfibrozil 600mg daily (increased risk of myopathy with concomitant statin)
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
            </ul>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  PCSK9
                 </span>
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 inhibitor
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  requires referral to Lipid Clinic
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-left:25px">
        </p>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="vertical-align:baseline">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                VA-
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Specific
                </span>
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Guidelines
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 https://www.healthquality.va.gov/guidelines/cd/lipids/index.asp
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Lowest
                 </span>
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 LDL goal recognized for VA Criteria for Use is 100
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Preferred statins:
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Atorvastatin, Simvastatin, Lovastatin
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Statins
                 </span>
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 that require PADR:
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Pravastatin, Rosuvastatin (2nd line high intensity statin)
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li style="margin-left: 10px;">
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  Must
                 </span>
                </span>
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  have documented intolerances or drug-drug interaction to all preferred statins
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="vertical-align:baseline">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Other agents that require PADR:
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="vertical-align:baseline">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Ezetimibe
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
            <ul>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    pt has tried and failed or not tolerated all statins (allergy, AE, etc.)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    pt not meeting goal on max dose of statin PLUS bile acid sequestrants or niacin
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
            </ul>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="vertical-align:baseline">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Fenofibrate
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
            <ul>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    Pt has tried all formulary alternatives or has contraindication to use of formulary alternatives (statin, niacin, gemfibrozil, cholestyramine, fish oil)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    If TG > 500 mg/dL, fenofibrate should be approved
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
       </div>
       <p>
       </p>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>